ZEGA Investments LLC Purchases Shares of 629 Axon Enterprise, Inc. (NASDAQ:AXON)

ZEGA Investments LLC acquired a new stake in Axon Enterprise, Inc. (NASDAQ:AXON) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 629 shares of the biotechnology company’s stock, valued at approximately $384,000.

A number of other hedge funds also recently modified their holdings of the stock. Asset Dedication LLC raised its holdings in Axon Enterprise by 11.3% in the 4th quarter. Asset Dedication LLC now owns 178 shares of the biotechnology company’s stock valued at $106,000 after acquiring an additional 18 shares during the period. Bleakley Financial Group LLC increased its stake in shares of Axon Enterprise by 1.3% during the fourth quarter. Bleakley Financial Group LLC now owns 1,527 shares of the biotechnology company’s stock worth $908,000 after purchasing an additional 20 shares during the period. Venturi Wealth Management LLC increased its stake in shares of Axon Enterprise by 2.7% during the fourth quarter. Venturi Wealth Management LLC now owns 802 shares of the biotechnology company’s stock worth $477,000 after purchasing an additional 21 shares during the period. Insigneo Advisory Services LLC lifted its holdings in Axon Enterprise by 1.4% during the 3rd quarter. Insigneo Advisory Services LLC now owns 1,568 shares of the biotechnology company’s stock worth $627,000 after purchasing an additional 22 shares during the last quarter. Finally, Menard Financial Group LLC boosted its stake in Axon Enterprise by 0.8% in the 3rd quarter. Menard Financial Group LLC now owns 3,014 shares of the biotechnology company’s stock valued at $1,204,000 after purchasing an additional 24 shares during the period. Institutional investors and hedge funds own 79.08% of the company’s stock.

Axon Enterprise Trading Up 0.3 %

Shares of AXON opened at $560.00 on Friday. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. Axon Enterprise, Inc. has a 52-week low of $273.52 and a 52-week high of $715.99. The firm has a market cap of $42.91 billion, a price-to-earnings ratio of 144.70, a PEG ratio of 5.17 and a beta of 1.12. The business’s fifty day moving average is $591.90 and its 200-day moving average is $540.96.

Insider Activity at Axon Enterprise

In other Axon Enterprise news, Director Jeri Williams sold 307 shares of the firm’s stock in a transaction that occurred on Monday, March 17th. The shares were sold at an average price of $552.72, for a total value of $169,685.04. Following the sale, the director now owns 1,627 shares in the company, valued at $899,275.44. This trade represents a 15.87 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. Also, insider Jeffrey C. Kunins sold 1,035 shares of the company’s stock in a transaction on Monday, December 23rd. The stock was sold at an average price of $624.47, for a total transaction of $646,326.45. Following the transaction, the insider now owns 124,243 shares of the company’s stock, valued at $77,586,026.21. This trade represents a 0.83 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 1,792 shares of company stock valued at $1,087,843 over the last ninety days. 5.70% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently weighed in on the company. Northcoast Research downgraded Axon Enterprise from a “buy” rating to a “neutral” rating in a report on Wednesday, February 19th. The Goldman Sachs Group lifted their price objective on shares of Axon Enterprise from $500.00 to $700.00 and gave the stock a “buy” rating in a research note on Monday, January 27th. Needham & Company LLC restated a “buy” rating and set a $600.00 target price on shares of Axon Enterprise in a research report on Wednesday, February 26th. Morgan Stanley upgraded shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and lifted their price target for the company from $500.00 to $700.00 in a research report on Tuesday, December 3rd. Finally, TD Cowen started coverage on Axon Enterprise in a research report on Wednesday, January 8th. They set a “buy” rating and a $700.00 price target on the stock. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and eleven have given a buy rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $604.67.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.